Results 31 to 40 of about 4,602,840 (385)
Standard treatment for Glanzmann thrombasthenia is platelet transfusion. Recombinant activated factor VII has been shown to be successful in patients with Glanzmann thrombasthenia with platelet antibodies or who are refractory to platelet transfusions ...
Giovanni Di Minno+5 more
doaj +1 more source
BackgroundMinimal residual disease (MRD) monitoring is an important tool to optimally address post-transplant management of acute myeloid leukemia (AML) patients.MethodsWe retrospectively analyzed the impact of bone marrow CD34+ molecular chimerism and ...
Michele Malagola+18 more
doaj +1 more source
Plasma histamine and coagulation time of the blood in dogs after administration of different histamine releasers [PDF]
Compound 48/80, sinomenine, tween 20 and polyvinylpyrrolidone (PVP) were injected intravenously to dogs, in doses producing similar degree of profound hypotension, and changes in the plasma histamine content and coagulation time were followed on the ...
Endo, Koiti+2 more
core +1 more source
Improved Visualization of the Necrotic Zone after Microwave Ablation Using Computed Tomography Volume Perfusion in an In Vivo Porcine Model [PDF]
After hepatic microwave ablation, the differentiation between fully necrotic and persistent vital tissue through contrast enhanced CT remains a clinical challenge.
Bressem, Keno K.+8 more
core +1 more source
The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
Background Standard treatment for Glanzmann thrombasthenia (GT), a severe inherited bleeding disorder, is platelet transfusion. Recombinant activated factor VII (rFVIIa) is reported to be effective in GT with platelet antibodies and/or refractoriness to ...
Rainer B. Zotz+3 more
doaj +1 more source
Snake venom metalloproteases, in addition to their contribution to the digestion of the prey, affect various physiological functions by cleaving specific proteins.
R. Kini+3 more
semanticscholar +1 more source
Modelling of thrombin generation under flow in realistic left anterior descending geometries [PDF]
Currently there are no available methods for prediction of thrombotic complications in Coronary Artery disease. Additionally, blood coagulation tests are mainly performed in a steady system while coagulation in vivo occurs under flow conditions.
Gavaises, M.+2 more
core +2 more sources
ACTION OF HIGH-DISPERSED SILICA ON BLOOD COAGULATION FACTORS ACTIVATION [PDF]
Using of high-dispersed silica based sorbents is a new and prospective method of bleeding arrest. Studies of high-dispersed silica haemostatic action during superficial wounds were promising for its surgery usage. However the mechanisms of haemostatic
T. M. Chernyshenko+6 more
doaj +1 more source
Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases
Blood coagulation factors and other proteins, with modulatory effects or modulated by the coagulation cascade have been reported to affect the pathophysiology of the central nervous system (CNS).
C. De Luca+3 more
semanticscholar +1 more source
Blood coagulation from the beginning until to-day [PDF]
The authors give an account of the important developments in blood coagulation knowledge from the times of Malpighi and Moravitz to data. The article is followed by original tables providing a general and comprehensive view on blood coagulation ...
Szirmai, Endre
core +1 more source